Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate

Helicobacter

Volumn 12, Issue 6, 2007, Pages 638-642

  Choi, Hyo Sun ^a   Park, Dong Il ^a   Hwang, Sang Jun ^a   Park, Jung Sik ^a   Kim, Hong Joo ^a   Cho, Yong Kyun ^a   Sohn, Chong Il ^a   Jeon, Woo Kyu ^a   Kim, Byung Ik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Helicobacter pylori; Non ulcer dyspepsia; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; BITTER TASTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ULCER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS;

HELICOBACTER PYLORI;

EID: 36248940756     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00556.x     Document Type: Article

References (36)

1. Buckley M, O'Morain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia. Aliment Pharmacol Ther 1995 9 (Suppl. 2 53 8.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 1 : 1311 5.
3. Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am 2005 89 : 313 44.
4. McNamara D, Buckley M, Gilvarry J, O'Morain C. Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study. Helicobacter 2002 7 : 317 21.
5. Tytgat GN. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease. Aliment Pharmacol Ther 1995 9 (Suppl. 1 39 42.
6. Uemura N, Okamoto S. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am 2000 29 : 819 27.
7. Anagnostopoulos GK, Tsiakos S, Margantinis G, Kostopoulos P, Arvanitidis D. Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. J Clin Gastroenterol 2004 38 : 503 6.
8. Schmid CH, Whiting G, Cory D, Ross SD, Chalmers TC. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther 1999 6 : 25 36.
9. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Alpert LC, Genta RM. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992 102 : 493 6.
10. Wang X, Fang JY, Lu R, Sun DF. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori. Digestion 2006 73 : 178 86.
11. Ishizaki T, Horai Y. cytochrone P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole. Aliment Pharmacolo Ther 1999 12 (Suppl. 3 27S 36S.
12. Horai Y, Kimura M, Furuie H, et al. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes. Aliment Pharmacol Ther 2001 15 : 793 803.
13. Hassan-Alin M, Andersson T, Bredberg E, Rohss K. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur J Clin Pharmacol 2000 56 : 665 70.
14. Dent J. Review article: pharmacology of esomeprazole and comparisons with omeprazole. Aliment Pharmacol Ther 2003 17 (Suppl. 1 5 9.
15. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000 14 : 963 78.
16. Catalano F, Branciforte G, Catanzaro R, Bentivegna C, Cipolla R, Nuciforo G, Brogna A. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. Helicobacter 1999 4 : 178 84.
17. Miwa H, Yamada T, Sato K, Ohta K, Ohkura R, Murai T, Nagahara A, Takei Y, Ogihara T, Sato N. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. Dig Dis Sci 2000 45 : 77 82.
18. Spinzi GC, Bierti L, Bortoli A, Colombo E, Fertitta AM, Lanzi GL, Venturelli R, Minoli G. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998 12 : 433 8.
19. Spencer CM, Faulds D. Esomeprazole. Drugs 2000 60 : 321 9.
20. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 2002 62 : 1503 38.
21. Johnson TJ, Hedge DD Esomeprazole: a clinical review. Am J Health Syst Pharm 2002 59 : 1333 9.
22. Johnson DA. Review of esomeprazole in the treatment of acid disorders. Expert Opin Pharmacother 2003 4 : 253 64.
23. Kale-Pradhan PB, Landry HK, Sypula WT. Esomeprazole for acid peptic disorders. Ann Pharmacother 2002 36 : 655 63.
24. Gatta L, Perna F, Figura N, Ricci C, Holton J, D'Anna L, Miglioli M, Vaira D. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother 2003 51 : 439 42.
25. Hsu PI, Lai KH, Lin CK, et al. A prospective randomized trial of esomeprazole-versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol 2005 100 : 2387 92.
26. Gisbert JP, Dominguez-Munoz A, Dominguez-Martin A, Gisbert JL, Marcos S. Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? Am J Gastroenterol 2005 100 : 1935 40.
27. Sheu BS, Kao AW, Cheng HC, Hunag SF, Chen TW, Lu CC, Wu JJ. Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. Aliment Pharmacol Ther 2005 21 : 283 8.
28. Manes G. Helicobacter pylori eradication, CYP2C19 and omeprazole doses. Aliment Pharmacol Ther 2005 22 : 273 4 author reply 274.
29. Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH. The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol 2006 101 : 1467 75.
30. Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 2001 13 : 1303 7.
31. Catalano F, Catanzaro R, Brogna A. Duodenal ulcer and functional dyspepsia: different susceptibility of Helicobacter pylori to eradicating therapy (Abstract). Gastroenterology 1997 112 : 84.
32. Gutierrez O, Otero W, Melo M. Helicobacter pylori eradication: duodenal ulcer vs. functional dyspepsia (Abstract). Gastroenterology 1998 114 : 142.
33. De Francesco V, Sgarro C, Cela E. Helicobacter pylori eradication rates in non-ulcer dyspepsia (nud) and duodenal ulcer (du) patients (Abstract). Gut 2001 49 (Suppl. 2 94.
34. Georgopoulos SD, ladas SD, Karatapanis S. Dose follicular gastritis adversely affect H. pylori eradication rate? (Abstract). Gut 1997 41 (Suppl. 1 97.
35. Cardenas VM, Graham DY, El-Zimaity HM, Opekun AR, Campos A, Chavez A, Guerrero L. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther 2006 23 : 295 301.
36. Kim JM. Antibiotic resistance of Helicobacter pylori isolated from Korean patients. Korean J Gastroenterol 2006 47 : 337 49.